New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study finds cycling JAK inhibitors to be an effective option for patients with difficult-to-treat rheumatoid arthritis

Study finds cycling JAK inhibitors to be an effective option for patients with difficult-to-treat rheumatoid arthritis

by American College of RheumatologyCredit: Unsplash/CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that peo
Immunology & Rheumatology May 29,2024
Study finds cycling JAK inhibitors to be an effective option for patients with difficult-to-treat rheumatoid arthritis

Study finds cycling JAK inhibitors to be an effective option for patients with difficult-to-treat rheumatoid arthritis

by American College of RheumatologyCredit: Unsplash/CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that peo
Immunology & Rheumatology May 29,2024
High-intensity strength training no added benefit for knee osteoarthritis

High-intensity strength training no added benefit for knee osteoarthritis

High-intensity strength training does not significantly improve knee pain with osteoarthritis compared with low-intensity strength training or a control condition, according to a study published in th
Immunology & Rheumatology May 29,2024
High-intensity strength training no added benefit for knee osteoarthritis

High-intensity strength training no added benefit for knee osteoarthritis

High-intensity strength training does not significantly improve knee pain with osteoarthritis compared with low-intensity strength training or a control condition, according to a study published in th
Immunology & Rheumatology May 29,2024
App to monitor rheumatoid arthritis symptoms does not improve disease outcomes

App to monitor rheumatoid arthritis symptoms does not improve disease outcomes

(HealthDay)—Use of a smartphone application (app) to monitor patient-reported outcomes does not improve satisfaction or disease outcomes in rheumatoid arthritis (RA), but patients are likely to recomm
Immunology & Rheumatology May 29,2024
App to monitor rheumatoid arthritis symptoms does not improve disease outcomes

App to monitor rheumatoid arthritis symptoms does not improve disease outcomes

(HealthDay)—Use of a smartphone application (app) to monitor patient-reported outcomes does not improve satisfaction or disease outcomes in rheumatoid arthritis (RA), but patients are likely to recomm
Immunology & Rheumatology May 29,2024
Abatacept therapy offers promising results for treating juvenile dermatomyositis

Abatacept therapy offers promising results for treating juvenile dermatomyositis

by George Washington UniversityScreening, Trial Entry and Outcome. Credit:Arthritis & Rheumatology(2023). DOI: 10.1002/art.42450Juvenile dermatomyositis, a rare but often severe a
Immunology & Rheumatology May 29,2024
Abatacept therapy offers promising results for treating juvenile dermatomyositis

Abatacept therapy offers promising results for treating juvenile dermatomyositis

by George Washington UniversityScreening, Trial Entry and Outcome. Credit:Arthritis & Rheumatology(2023). DOI: 10.1002/art.42450Juvenile dermatomyositis, a rare but often severe a
Immunology & Rheumatology May 29,2024
New 3-D imaging analysis technique could lead to improved arthritis treatment

New 3-D imaging analysis technique could lead to improved arthritis treatment

by University of CambridgeJoint space in hip, knee and ankle joints as analyzed by the JSM algorithm. Credit: Tom TurmezeiAn algorithm to monitor the joints of patients with arthritis, which coul
Immunology & Rheumatology May 29,2024
New 3-D imaging analysis technique could lead to improved arthritis treatment

New 3-D imaging analysis technique could lead to improved arthritis treatment

by University of CambridgeJoint space in hip, knee and ankle joints as analyzed by the JSM algorithm. Credit: Tom TurmezeiAn algorithm to monitor the joints of patients with arthritis, which coul
Immunology & Rheumatology May 29,2024
Improving uniformity and quality of care for people undergoing intra-articular injection

Improving uniformity and quality of care for people undergoing intra-articular injection

by EULARCredit: CC0 Public DomainIntra-articular therapies (IAT) are frequently used to treat joint conditions such as gout, rheumatoid arthritis, or osteoarthritis. The procedure involves inserting a
Immunology & Rheumatology May 29,2024
Improving uniformity and quality of care for people undergoing intra-articular injection

Improving uniformity and quality of care for people undergoing intra-articular injection

by EULARCredit: CC0 Public DomainIntra-articular therapies (IAT) are frequently used to treat joint conditions such as gout, rheumatoid arthritis, or osteoarthritis. The procedure involves inserting a
Immunology & Rheumatology May 29,2024
Early therapy for rheumatoid arthritis may slow heart disease

Early therapy for rheumatoid arthritis may slow heart disease

(HealthDay)—Disease-modifying antirheumatic drug (DMARD) therapy for rheumatoid arthritis (RA) treatment also cuts cardiovascular disease (CVD) risk, according to a study published online Aug. 28 in t
Immunology & Rheumatology May 29,2024
Early therapy for rheumatoid arthritis may slow heart disease

Early therapy for rheumatoid arthritis may slow heart disease

(HealthDay)—Disease-modifying antirheumatic drug (DMARD) therapy for rheumatoid arthritis (RA) treatment also cuts cardiovascular disease (CVD) risk, according to a study published online Aug. 28 in t
Immunology & Rheumatology May 29,2024
Research investigating links between viruses and Alzheimer's was dismissed for years, but now the evidence is building

Research investigating links between viruses and Alzheimer's was dismissed for years, but now the evidence is building

by Ruth Itzhaki,The ConversationCredit: AI-generated imageWhen I was about seven or eight, I asserted that I wanted to be a scientist, or so my parents told me years later, even though I would h
Neurology May 28,2024
Research investigating links between viruses and Alzheimer's was dismissed for years, but now the evidence is building

Research investigating links between viruses and Alzheimer's was dismissed for years, but now the evidence is building

by Ruth Itzhaki,The ConversationCredit: AI-generated imageWhen I was about seven or eight, I asserted that I wanted to be a scientist, or so my parents told me years later, even though I would h
Neurology May 28,2024
New target for Alzheimer's therapies found

New target for Alzheimer's therapies found

by German Center for Neurodegenerative DiseasesMedin interacts directly with amyloid-β, promoting its aggregation.a, Immuno-electron microscopy of MFG-E8 (or fragment) staining in cortical
Neurology May 28,2024
New target for Alzheimer's therapies found

New target for Alzheimer's therapies found

by German Center for Neurodegenerative DiseasesMedin interacts directly with amyloid-β, promoting its aggregation.a, Immuno-electron microscopy of MFG-E8 (or fragment) staining in cortical
Neurology May 28,2024
Guidance on new treatments for early Alzheimer's disease issued

Guidance on new treatments for early Alzheimer's disease issued

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainNew therapies for early Alzheimer's disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing ho
Neurology May 28,2024
Guidance on new treatments for early Alzheimer's disease issued

Guidance on new treatments for early Alzheimer's disease issued

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainNew therapies for early Alzheimer's disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing ho
Neurology May 28,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com